Feedback
Settings

Settings

Goto Application

1. WO2021002776 - IMMUNOBIOLOGICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2

Submit observation
PermaLink
Publication Number WO/2021/002776
Publication Date 07.01.2021
International Application No. PCT/RU2020/000344
International Filing Date 13.07.2020
IPC
A61K 39/215 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
A61P 31/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
CPC
A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
A61K 39/215
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
A61P 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C12N 2710/10343
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2710dsDNA Viruses
00011dsDNA Viruses
10011Adenoviridae
10311Mastadenovirus, e.g. human or simian adenoviruses
10341Use of virus, viral particle or viral elements as a vector
10343viral genome or elements thereof as genetic vector
C12N 2770/20034
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
20011Coronaviridae
20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applicants
  • FEDERAL STATE BUDGETARY INSTITUTION "NATIONAL RESEARCH CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAMED AFTER THE HONORARY ACADEMICIAN N.F. GAMALEYA" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION [RU]/[RU]
Inventors
  • ZUBKOVA, Olga Vadimovna
  • OZHAROVSKAIA, Tatiana Andreevna
  • DOLZHIKOVA, Inna Vadimovna
  • POPOVA, Olga
  • SHCHEBLIAKOV, Dmitrii Viktorovich
  • GROUSOVA, Daria Mikhailovna
  • DZHARULLAEVA, Alina Shahmirovna
  • TUKHVATULIN, Amir Ildarovich
  • TUKHVATULINA, Natalia Mikhailovna
  • SHCHERBININ, Dmitrii Nikolaevich
  • ESMAGAMBETOV, Ilias Bulatovich
  • TOKARSKAYA, Elizaveta Alexandrovna
  • BOTIKOV, Andrei Gennadevich
  • BORISEVICH, Sergey Vladimirovich
  • NARODITSKY, Boris Savelievich
  • LOGUNOV, Denis Yuryevich
  • GINTSBURG, Aleksandr Leonidovich
Agents
  • SIMAKINA, Olga Vasilevna
Priority Data
202011442423.04.2020RU
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) IMMUNOBIOLOGICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2
(FR) AGENT IMMUNOBIOLOGIQUE POUR INDUIRE UNE IMMUNITÉ SPÉCIFIQUE CONTRE LE CORONAVIRUS DU SYNDROME RESPIRATOIRE AIGU SÉVÈRE 2 (SRAS-COV-2)
front page image
Abstract
(EN)
The invention relates to biotechnology, immunology and virology and, in particular, to an immunobiological agent for the prevention of diseases caused by severe acute respiratory syndrome virus SARS-CoV-2. Also, a method of inducing specific immunity to the SARS-CoV-2 virus is disclosed, comprising the administration to mammals of one or more immunobiological agents for the prevention of diseases caused by severe acute respiratory syndrome virus SARS-CoV-2. The invention facilitates an effective induction of the immune response to the SARS-CoV-2 virus.
(FR)
L'invention concerne la biotechnologie, l'immunologie et la virologie et, en particulier, un agent immunobiologique pour la prévention de maladies provoquées par le coronavirus du syndrome respiratoire aigu sévère 2 (SARS-CoV-2). L'invention concerne également un procédé d'induction d'une immunité spécifique au virus SARS-CoV-2, comprenant l'administration à des mammifères d'un ou de plusieurs agents immunobiologiques pour la prévention de maladies provoquées par le coronavirus du syndrome respiratoire aigu sévère 2. L'invention facilite une induction efficace de la réponse immunitaire au virus SARS-CoV-2.
Also published as
EA202000368
Latest bibliographic data on file with the International Bureau
# -